Navigation Links
Marco RT-300

ProductsMarco RT-300
Company Marco Ophthalmic, Inc.
Item Marco RT-300
Features Sealed in rear with replaceable plano lens. Fully synchronized cross cylinders, or optional split- image cross cylinders. Anti reflective coating on lenses. Near tests. Bi-loupe turret system. Large, legible high contrast number scales. Selection of auxiliary lenses. Conveniently located knobs.
Description Manual refractor. The RT-300's accessory knob is positioned next to the cylinder power/axis knob and all controls are within a hand's breadth of each other. Cylinder power up to +-6.00D; sphere power from +16.75 to -19.00D. "Sure-grip" knurls on the control knobs make them easy to grasp. Combined with the convenient placement of the controls themselves, this helps reduce fatigue. Fully synchronized cross-cylinder is standard. Large high-contrast numbers on the instrument scales make them easy to read even in subdued light.
Info Marco Ophthalmic, Inc.
Customer Service: (800) 874-5274
Web site: http://www.marcooph.com/home.html

Related medicine products :

1. Marco Surgiscope 3
2. Marco CP-1 Chart Projector
3. Marco LM-970
4. Marco LM-990A
5. Marco Spectrum 2
6. National Eyewear Collection by Marcolin
7. Marcolin Eyewear Collection
TAG: Marco
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products:
(Date:12/1/2008)...tion Health Care has been ranked,the nation,s 19t...hcare,magazine. The national award recognizes Res...communities, home health services, behavioral heal...cago area. , Modern Healthcare,s Best Place...tions nationwide that enable employees to perform ...
(Date:12/1/2008)... PAREXEL International Corporation,(Nasdaq: PRX...ASDAQ OMX 22nd,Investor Program in London, Englan...utive Officer will be making a formal presentation...er 4, 2008. A live webcast of this presentation,...ion on PAREXEL,s "Investors",homepage at www.PAR...
(Date:12/1/2008)...ntly updated its traumatic brain injury (TBI) blog...r,s family who have taken on the role of caregiver...soldiers returning from Iraq is a traumatic brain ...rning them into care providers. , ...galView.com, the number one online legal resource ...
(Date:12/1/2008)... cancer who have undergone breast augmentation may...iation treatment called brachytherapy, according t... the Radiological Society of North America (RSNA)....osmetic outcomes and avoid the risk of the implant...-breast radiation therapy. , "We are seeing an i...
Breaking Medicine News(10 mins):Health News:Resurrection Health Care Named One of Nation's 'Best Places to Work in Healthcare' 2Health News:PAREXEL International to Present at NASDAQ OMX 22nd Investor Program 2Health News:LegalView Updates Brain Injury Site with Information on TBI Disabled Soldier's Family 2Health News:LegalView Updates Brain Injury Site with Information on TBI Disabled Soldier's Family 3Health News:Breast cancer treatment offers better outcome to women with implants 2
...stralia for Type 2 Diabetes appears to have a twin...ood sugar under control// but also helps them to l...ho is an associate Professor with the Royal Prince...rently this drug has been under trial on patient v...
...eggs in southern Vietnam have plummeted after test...unts of a carcinogenic agent//, media reported Mon...ed to 400,000-500,000 normally," Pham Thi Huan, he...g supplier, told the Thanh Nien online newspaper. ...
...entist in the US has reiterated that some general ...in disorders// in elderly patients. A study led ...edical School, US, found that halothane and isoflu...ed - and the injected drug propofol cause symptoms...
...is fueling the spread of HIV in the population. So...inue to undermine prevention// and education effor...orum in Nairobi, Kenya, Inter Press Service report...V infection among many women; violence in the home...
Other Medicine News:Health News:Anaesthetics may Cause Brain Disorder in Elderly 2Health News:Violence Against Women Fueling Spread of HIV Worldwide 2
(Date:11/25/2008)...nding statin use broadly in wake of AHA-presented ...wswire/ -- JUPITER, a clinical trial suggesting ro...althy patients with elevated CRP, should not promp...to a national poll directed at health professional... poll conducted by medical news site MedPage Today...
(Date:11/25/2008)...Call/ -- Pharmacyclics, Inc.,(Nasdaq: PCYC ) to...se 1,clinical trial with PCI-27483, the company,s... inhibitor. The trial was conducted in sixteen (16...harmacologic effect of,PCI-27483. A single admini...esponse in the International Normalized Ratio (INR...
(Date:11/24/2008)...PRNewswire/ -- Takeda Pharmaceutical Company Limit...Research & Development Center, Inc., U.S., ann... of the U.S. Food and Drug Administration (FDA) re... treatment of hyperuricemia in patients with gout....h one panel member abstaining. The vote followed p...
(Date:11/24/2008)...h , , Oak Brook, Ill., Nov. 24 /PRNewswire-...estinal Endoscopy (ASGE) and the Pancreatic Cancer...ise awareness about pancreatic cancer, educating p...re available for them. , , Pancreatic cance...the U.S. In 2008, an estimated 37,680 Americans wi...
Breaking Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury Thomson Financial Investment Conference 329 1Oncolytics Biotech Inc Announces Issuance of 23rd U S Patent 324 1Oncolytics Biotech Inc Announces Issuance of 23rd U S Patent 324 2Quark Pharmaceuticals Appoints New Chief Medical Officer 180 1Quark Pharmaceuticals Appoints New Chief Medical Officer 180 2Quark Pharmaceuticals Appoints New Chief Medical Officer 180 3Quark Pharmaceuticals Appoints New Chief Medical Officer 180 4New Smart Technology Makes Patient Data Collection Easier More Efficient 414 1New Smart Technology Makes Patient Data Collection Easier More Efficient 414 2
..., March 14, 2007 /Xinhua-PRNewswire-FirstCall/,-- ...he results,from its Phase II trial for Aridol in s... (COPD), a respiratory disease,affecting over 30 m... in 79 diagnosed COPD patients at 12,centres in Au...,determine if subjects that were positive to an Ar...
...SS WIRE)--Mar 14, 2007 - Sequenom, Inc. (NASDAQ:,S...ogy and,iPLEX(TM) assay were used by leading scien..., in independent studies, significantly,advanced t...stant,malaria. Results from several of these studi...ed journals as follows:, -- In "High-Throughput On...
Other Medicine Technology:Pharmaxis Reports Phase II Results for Aridol in COPD 2Pharmaxis Reports Phase II Results for Aridol in COPD 3Pharmaxis Reports Phase II Results for Aridol in COPD 4Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 2Use of Sequenom's MassARRAY System Leads to Significant Scientific,Advances in Understanding Cancer, Diabetes and Drug-Resistant,Malaria 3